Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques P Tremblay

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Transplantation|June 27, 2008
Central tolerance to myogenic cell transplants does not include muscle neoantigensGeoffrey Camirand, Lionel Stéphan, Joël Rousseau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblastsSimon P Quenneville, Pierre Chapdelaine, Joël Rousseau, et al.
Journal of Neuropathology and Experimental Neurology|May 16, 2024
Human MuStem cells are competent to fuse with nonhuman primate myofibers in a clinically relevant transplantation context: A proof-of-concept studyMarine Charrier, Isabelle Leroux, Julien Pichon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Expression of dog microdystrophin in mouse and dog muscles by gene therapyChristophe Pichavant, Pierre Chapdelaine, Daniel G Cerri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patientsDavid G Ousterout, Pablo Perez-Pinera, Pratiksha I Thakore, et al.
The CRISPR Journal|June 22, 2023
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13Gabriel Lamothe, Julie Carbonneau, Charles Joly Beauparlant, et al.
Brain, Behavior, and Immunity|June 18, 2018
Nonfunctional mutant Wrn protein leads to neurological deficits, neuronal stress, microglial alteration, and immune imbalance in a mouse model of Werner syndromeChin Wai Hui, Marie-Kim St-Pierre, Jérôme Detuncq, et al.
Journal of Neuropathology and Experimental Neurology|May 13, 2006
Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cellsDaniel Skuk, Marlyne Goulet, Brigitte Roy, et al.
The Journal of Cell Biology|July 30, 2003
Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy modelYvan Torrente, Geoffrey Camirand, Federica Pisati, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 25, 2004
Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cellsDaniel Skuk, Brigitte Roy, Marlyne Goulet, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Transplantation|June 27, 2008
Central tolerance to myogenic cell transplants does not include muscle neoantigensGeoffrey Camirand, Lionel Stéphan, Joël Rousseau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblastsSimon P Quenneville, Pierre Chapdelaine, Joël Rousseau, et al.
Journal of Neuropathology and Experimental Neurology|May 16, 2024
Human MuStem cells are competent to fuse with nonhuman primate myofibers in a clinically relevant transplantation context: A proof-of-concept studyMarine Charrier, Isabelle Leroux, Julien Pichon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Expression of dog microdystrophin in mouse and dog muscles by gene therapyChristophe Pichavant, Pierre Chapdelaine, Daniel G Cerri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patientsDavid G Ousterout, Pablo Perez-Pinera, Pratiksha I Thakore, et al.
The CRISPR Journal|June 22, 2023
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13Gabriel Lamothe, Julie Carbonneau, Charles Joly Beauparlant, et al.
Brain, Behavior, and Immunity|June 18, 2018
Nonfunctional mutant Wrn protein leads to neurological deficits, neuronal stress, microglial alteration, and immune imbalance in a mouse model of Werner syndromeChin Wai Hui, Marie-Kim St-Pierre, Jérôme Detuncq, et al.
Journal of Neuropathology and Experimental Neurology|May 13, 2006
Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cellsDaniel Skuk, Marlyne Goulet, Brigitte Roy, et al.
The Journal of Cell Biology|July 30, 2003
Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy modelYvan Torrente, Geoffrey Camirand, Federica Pisati, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 25, 2004
Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cellsDaniel Skuk, Brigitte Roy, Marlyne Goulet, et al.
Pageof 14